Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEHP.L Share News (EHP)

  • There is currently no data for EHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Neptune Calculus Income & Growth VCT Hit By Epistem Share Decline

Tue, 19th Nov 2013 15:56

LONDON (Alliance News) - Neptune-Calculus Income & Growth VCT PLC Tuesday said its net asset value per share declined by 4.9% during the third quarter, as a result of a decline in the share price of AIM-quoted Epistem Holdings PLC, one of the companies in which it invests.

"[Epistem] although still valued at 300% of original cost, saw a decline it its share price following the termination of a supply and distribution agreement with Becton Dickinson for its product "Genedrive"," Neptune said in a statement.

Neptune said it is still positive on Epistem's long-term prospects. Epistem shares were Tuesday quoted at 323.00, down 2.2% and not much above their 52-week low of 310.00 pence. The shares have traded as high as 585.00 pence in the period.

Neptune said the remainder of the quoted portfolio increased by 30% on a like-for-like basis compared with the FTSE All Share which increased by 4.7%

Neptune's net asset value per share was 52.69 pence on September 30, compared to 55.43 pence on June 30.

Shares in Neptune were Tuesday quoted at 40.00 pence, up 14%.

By Samuel Agini; samagini@alliancenews.com; @samuelagini

Copyright © 2013 Alliance News Limited. All Rights Reserved.

More News
25 Jul 2016 07:51

Epistem Changes Name To Genedrive To Better Reflect Company Focus

Read more
12 Jul 2016 16:31

CORRECT: DIRECTOR DEALINGS: Epistem Directors Take Part In Placing

Read more
12 Jul 2016 12:08

DIRECTOR DEALINGS: Epistem Holdings Directors Take Part In Placing

Read more
23 Jun 2016 07:13

Epistem Urges Shareholders To Back Placing As Cash Begins To Dwindle (ALLISS)

Read more
7 Jun 2016 08:42

Epistem Secures Cornerstone Investor For Planned Fundraising (ALLISS)

Read more
3 May 2016 07:11

Epistem Says Genedrive Human Genotyping Trial Completed Successfully

Read more
18 Apr 2016 08:59

Epistem Starts Full Indian Commercial Launch For Genedrive

Read more
31 Mar 2016 09:33

WINNERS & LOSERS SUMMARY: AO World Surges On Strong Fourth Quarter

Read more
31 Mar 2016 08:42

Epistem Loss Widens As Focus Remains On Product Launch

Read more
21 Mar 2016 15:37

US DoD awards another £2m for Epistem biohazard project

(ShareCast News) - Epistem Holdings was gearing up for the next stage of its development programme with the US Department of Defense on Monday, having been awarded funding to proceed. The AIM-traded company received $2.4m (£1.7m) for the first phase of the $7.8m programme in August last year, to dev

Read more
21 Mar 2016 08:50

Epistem Gets USD2.9 Million Funding For Biohazard Identification Test

Read more
18 Feb 2016 08:00

Epistem Says First Test On Hepatitis C Test Completed Successfully

Read more
22 Jan 2016 09:59

River & Mercantile UK Micro Cap Beats Index, Says Epistem "Hidden Gem"

Read more
13 Jan 2016 09:11

Epistem Holdings Appoints David Budd As New Chief Executive

Read more
16 Dec 2015 14:29

DIRECTOR DEALINGS: Epistem Executives Buy 60,000 Shares

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.